Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of Adverse Events
| Placebo (N = 46) | Palifermin (N = 48) | |
|---|---|---|
| Adverse events (AEs) | 45 (98) | 48 (100) |
| Serious AEs | 30 (65) | 21 (44) |
| Treatment-related AEs | 6 (13) | 13 (27) |
| Serious AEs | 4 (9) | 2 (4) |
| Most frequent (≥5%) treatment-related AEs | ||
| Rash | 3 (7) | 2 (4) |
| Diarrhea | 0 (0) | 3 (6) |
| Erythema | 0 (0) | 3 (6) |
| Flushing | 0 (0) | 3 (6) |
| Incidence of second primary tumors | 0 (0) | 0 (0) |
| Unresolved grade ≥2 dysphagia at month 6 | 2 (4) | 0 (0) |
| On-study death | 5 (11) | 2 (4) |
Values are given as n (%).
